ENvue Medical, Inc.
FEED
$0.81
-$0.02-2.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 653.00K | 312.00K | 722.00K | 494.00K | 1.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 653.00K | 312.00K | 722.00K | 494.00K | 1.03M |
| Cost of Revenue | 708.00K | 682.00K | 533.00K | 529.00K | 656.00K |
| Gross Profit | -55.00K | -370.00K | 189.00K | -35.00K | 369.00K |
| SG&A Expenses | 3.19M | 3.25M | 2.22M | 2.97M | 1.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.36M | 3.97M | 2.97M | 4.47M | 2.88M |
| Operating Income | -3.71M | -3.66M | -2.25M | -3.98M | -1.85M |
| Income Before Tax | -3.79M | -13.27M | 545.00K | -3.91M | -1.86M |
| Income Tax Expenses | 33.00K | -419.00K | 35.00K | 62.00K | 15.00K |
| Earnings from Continuing Operations | -3.82M | -12.85M | 510.00K | -3.97M | -1.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.82M | -12.85M | 510.00K | -3.97M | -1.87M |
| EBIT | -3.71M | -3.66M | -2.25M | -3.98M | -1.85M |
| EBITDA | -3.49M | -3.40M | -1.99M | -3.61M | -1.83M |
| EPS Basic | -6.88 | -12.37 | -0.91 | -1.03 | -29.90 |
| Normalized Basic EPS | -0.72 | -1.21 | 0.40 | -5.03 | -18.54 |
| EPS Diluted | -6.88 | -12.37 | -0.91 | -1.03 | -29.90 |
| Normalized Diluted EPS | -0.72 | -1.21 | 0.40 | -5.03 | -18.54 |
| Average Basic Shares Outstanding | 3.29M | 1.10M | 858.40K | 484.60K | 62.60K |
| Average Diluted Shares Outstanding | 3.29M | 1.10M | 858.40K | 484.60K | 62.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |